Literature DB >> 18438646

The effects of methamphetamine on core body temperature in the rat--part 1: chronic treatment and ambient temperature.

Benita J Myles1, Lee Ann Jarrett, Susan L Broom, H Anton Speaker, Karen E Sabol.   

Abstract

RATIONALE: Stimulants such as methamphetamine (METH) alter core temperature in a manner that is dependent on ambient temperature and that shows tolerance after chronic use. Our objectives were to (1) determine whether tolerance to METH-induced hyperthermia was a consequence of neurotoxicity to dopamine or serotonin and (2) determine the relationship between ambient temperature and chronic treatment on the METH-induced temperature response.
MATERIALS AND METHODS: Rats were treated with 1.0, 5.0, or 10.0 mg/kg METH at 24 degrees C (experiment 1) or treated with 5.0 mg/kg METH at 20 degrees C, 24 degrees C, or 28 degrees C (experiment 2). Treatment occurred for 12 days, and temperature measurements were made once per minute telemetrically during 7-h sessions in computer-regulated environments.
RESULTS: Peak increases in core temperature occurred at 60 min post-treatment for the 1.0 and 10.0 mg/kg doses, and at 180 min for the 5.0 mg/kg dose. Tolerance-like effects were seen with chronic 5.0 (mixed results) and 10.0 mg/kg METH in the absence of dopamine or serotonin depletions measured 2 weeks after the completion of treatment. After 5.0 mg/kg METH, variations in ambient temperature resulted in an early flexible change in core temperature (phase 1) (hyperthermia at 28 degrees and hypothermia at 20 degrees ) and a later inflexible hyperthermia (phase 2).
CONCLUSIONS: The results suggest that (1) the peak effect of different doses of METH occurs at different times (24 degrees ), (2) the diminished temperature response with chronic METH treatment was not associated with long-term dopamine and serotonin depletions, and (3) a two-phase temperature response to METH may reflect two independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438646     DOI: 10.1007/s00213-007-1061-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  Tolerance to the neurotoxic effects of methamphetamine in young rats.

Authors:  Evan L Riddle; Jerry M Kokoshka; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2002-01-25       Impact factor: 4.432

2.  Cognitive performance of current methamphetamine and cocaine abusers.

Authors:  Sara L Simon; Catherine P Domier; Tiffanie Sim; Kimberly Richardson; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

3.  The effects of 6-hydroxydopamine, dopamine and dl-norepinephrine on food intake and water consumption, self-stimulation, temperature and electroencephalographic activity in the rat.

Authors:  M G Hansen; I Q Whishaw
Journal:  Psychopharmacologia       Date:  1973-02-27

4.  L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.

Authors:  C J Schmidt; C K Black; V L Taylor
Journal:  Eur J Pharmacol       Date:  1991-10-02       Impact factor: 4.432

5.  Persistence of tolerance to methamphetamine-induced monoamine deficits.

Authors:  Jonathan P Danaceau; Cassandra E Deering; Jayme E Day; Stacy J Smeal; Kamisha L Johnson-Davis; Annette E Fleckenstein; Diana G Wilkins
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

6.  Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).

Authors:  Jon E Sprague; Matthew L Banks; Valerie J Cook; Edward M Mills
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

7.  The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen.

Authors:  Benita J Myles; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2008-04-26       Impact factor: 4.530

8.  Altered responses to serotonergic agents in Fawn-Hooded rats.

Authors:  G A Gudelsky; J I Koenig; H Y Meltzer
Journal:  Pharmacol Biochem Behav       Date:  1985-03       Impact factor: 3.533

9.  3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors.

Authors:  Daniel E Rusyniak; Maria V Zaretskaia; Dmitry V Zaretsky; Joseph A DiMicco
Journal:  J Pharmacol Exp Ther       Date:  2007-08-16       Impact factor: 4.030

10.  Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.

Authors:  C E Cook; A R Jeffcoat; B M Sadler; J M Hill; R D Voyksner; D E Pugh; W R White; M Perez-Reyes
Journal:  Drug Metab Dispos       Date:  1992 Nov-Dec       Impact factor: 3.922

View more
  22 in total

1.  Prostaglandin riddles in energy metabolism: E is for excess, D is for depletion. Focus on "Food deprivation alters thermoregulatory responses to lipopolysaccharide by enhancing cryogenic inflammatory signaling via prostaglandin D2".

Authors:  Andrej A Romanovsky; Andras Garami
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-21       Impact factor: 3.619

2.  Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.

Authors:  Michelle G Baladi; Amy H Newman; Shannon M Nielsen; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2014-03-28       Impact factor: 4.432

3.  Methiopropamine and its acute behavioral effects in mice: is there a gray zone in new psychoactive substances users?

Authors:  Fabio De-Giorgio; Sabrine Bilel; Micaela Tirri; Raffaella Arfè; Claudio Trapella; Cristian Camuto; Federica Foti; Paolo Frisoni; Margherita Neri; Francesco Botrè; Matteo Marti
Journal:  Int J Legal Med       Date:  2020-05-01       Impact factor: 2.686

4.  Meth math: modeling temperature responses to methamphetamine.

Authors:  Yaroslav I Molkov; Maria V Zaretskaia; Dmitry V Zaretsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-05       Impact factor: 3.619

5.  Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.

Authors:  Nicholas B Miner; Josh S Elmore; Michael H Baumann; Tamara J Phillips; Aaron Janowsky
Journal:  Neurotoxicology       Date:  2017-09-15       Impact factor: 4.294

6.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.

Authors:  Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2015-05-01       Impact factor: 4.530

7.  Circadian variability of body temperature responses to methamphetamine.

Authors:  Abolhassan Behrouzvaziri; Maria V Zaretskaia; Daniel E Rusyniak; Dmitry V Zaretsky; Yaroslav I Molkov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-06       Impact factor: 3.619

8.  A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.

Authors:  Michelle L Miller; Amira Y Moreno; Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Brittani D Vaillancourt; M Jerry Wright; Kim D Janda; Michael A Taffe
Journal:  Biol Psychiatry       Date:  2012-10-23       Impact factor: 13.382

9.  The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.

Authors:  S M Aarde; P K Huang; K M Creehan; T J Dickerson; M A Taffe
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

10.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.